Report copyright - BLINCYTO™ (blinatumomab) Drug Class: Bispecific CD19 ... · Drug Class: Bispecific CD19-directed CD3 T-cell engager . Amgen Inc. One Amgen Center Drive Thousand Oaks, ... 3 years,
Please pass captcha verification before submit form